ENDRA Life Sciences

ENDRA Life Sciences NDRA Stock

$6.06   0.331126%
Add to favorites
Market Cap
$9.09M
LOW - HIGH [24H]
$5.91 - $6.17
VOLUME [24H]
$7.45K
P/E Ratio
0
Earnings per share
-$6.26
ISIN
US29273B5003
Price   Prediction

ENDRA Life Sciences Price Chart

Sorry, that's all we've gotfor now...

ENDRA Life Sciences NDRA Financial and Trading Overview

ENDRA Life Sciences stock price 6.06 USD
Previous Close 6.31 USD
Open 6.4 USD
Bid 4.29 USD x 200
Ask 7.52 USD x 200
Day's Range 6.22 - 6.4 USD
52 Week Range 2.96 - 9.85 USD
Volume 8.01K USD
Avg. Volume 36.41K USD
Market Cap 9.38M USD
Beta (5Y Monthly) -0.081
PE Ratio (TTM) N/A
EPS (TTM) -6.26 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 25 USD

NDRA Valuation Measures

Enterprise Value 8.15M USD
Trailing P/E N/A
Forward P/E -2.057566
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.4868078
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.233

Trading Information

ENDRA Life Sciences Stock Price History

Beta (5Y Monthly) -0.081
52-Week Change 0.31%
S&P500 52-Week Change 15.77%
52 Week High 9.85 USD
52 Week Low 2.96 USD
50-Day Moving Average 5.22 USD
200-Day Moving Average 4.78 USD

NDRA Share Statistics

Avg. Volume (3 month) 36.41K USD
Avg. Daily Volume (10-Days) 33.55K USD
Shares Outstanding 1.5M
Float 1.43M
Short Ratio 0.7
% Held by Insiders 13.56%
% Held by Institutions 17.98%
Shares Short 31.34K
Short % of Float 2.18%
Short % of Shares Outstanding 2.08%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:35

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -77.32%
Return on Equity (ttm) -152.044%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -6611182 USD
Net Income Avi to Common (ttm) -5916657 USD
Diluted EPS (ttm) -6.26
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.74M USD
Total Cash Per Share (mrq) 1.16 USD
Total Debt (mrq) 429.27K USD
Total Debt/Equity (mrq) 6.8 USD
Current Ratio (mrq) 7.103
Book Value Per Share (mrq) 4.207

Cash Flow Statement

Operating Cash Flow (ttm) -4822924 USD
Levered Free Cash Flow (ttm) -6733445 USD

Profile of ENDRA Life Sciences

Country United States
State MI
City Ann Arbor
Address 3600 Green Court
ZIP 48105-1570
Phone 734 335 0468
Website https://endrainc.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 9

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Q&A For ENDRA Life Sciences Stock

What is a current NDRA stock price?

ENDRA Life Sciences NDRA stock price today per share is 6.06 USD.

How to purchase ENDRA Life Sciences stock?

You can buy NDRA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ENDRA Life Sciences?

The stock symbol or ticker of ENDRA Life Sciences is NDRA.

Which industry does the ENDRA Life Sciences company belong to?

The ENDRA Life Sciences industry is Diagnostics & Research.

How many shares does ENDRA Life Sciences have in circulation?

The max supply of ENDRA Life Sciences shares is 1.5M.

What is ENDRA Life Sciences Price to Earnings Ratio (PE Ratio)?

ENDRA Life Sciences PE Ratio is now.

What was ENDRA Life Sciences earnings per share over the trailing 12 months (TTM)?

ENDRA Life Sciences EPS is -6.26 USD over the trailing 12 months.

Which sector does the ENDRA Life Sciences company belong to?

The ENDRA Life Sciences sector is Healthcare.

ENDRA Life Sciences NDRA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 27538.69 USD —
-0.22
6.33B USD — 27341.31 USD — 27547.2 USD — — 6.33B USD —
us US Tech Capital Market Composite RCMP US 125.68 USD —
-1.74
— — 125.28 USD — 126.01 USD — — — —
us US Tech Health Care IXHC US 1295.78 USD —
+0.26
— — 1284.67 USD — 1308.07 USD — — — —
$2.85T
Total marketcap
$108.12B
Total volume
BTC 58.82%   •   ETH 11.02%
Dominance
Select currency